Food and antibiotics may change microorganisms in gut, causing IBS

January 27, 2017, American Physiological Society

A recent review of research suggests that changes to the microorganisms (microbiota) in the gastrointestinal (GI) tract may be a cause of irritable bowel syndrome (IBS). The review article is published in the American Journal of Physiology—Gastrointestinal and Liver Physiology.

IBS is common—up to 20 percent of middle-aged North Americans suffer from IBS and chronic bowel disorder characterized by abdominal pain, gas, diarrhea or constipation or both. The disorder has been thought to be caused primarily by a combination of , environmental factors and genetics.

A research team from the Mayo Clinic in Rochester, Minn., analyzed studies about gut microbiota and IBS. This review led the team to make new observations about the development of the disease. Among the findings:

  • Diet can change the makeup of bacteria in the GI tract, potentially contributing to symptoms in patients with IBS;
  • Antibiotic use, which can disrupt gut microbiota is associated with IBS;
  • Changes in the gut microbiota may influence the ability of the GI tract to contract to move waste through the system; and
  • Changes in the can impair communication networks between the immune, nervous and endocrine systems, predisposing people to IBS symptoms.

The researchers also highlight data suggesting that emotional stress can change the shape and function of microorganisms in the GI tract. The correlation between physiological function of the digestive system and the risk of developing IBS is important because it allows for new treatment options in the future. "Overall, the outlook is optimistic, and we now have the necessary tools and the knowledge as we embark on developing effective microbiota targeted therapies for IBS," wrote the authors.

Explore further: Study provides clues to improving fecal microbiota transplantation

More information: Yogesh Bhattarai et al. Irritable bowel syndrome: a gut microbiota-related disorder?, American Journal of Physiology - Gastrointestinal and Liver Physiology (2017). DOI: 10.1152/ajpgi.00338.2016

Related Stories

Study provides clues to improving fecal microbiota transplantation

December 20, 2016
Results from a placebo-controlled trial provide a strategy for improving fecal microbiota transplantation (FMT) for patients with recurrent Clostridium difficile infection. The study, published online this week in mBio, an ...

What is the role of the gut microbiome in developing Parkinson's disease?

June 23, 2015
In recent years, an important Parkinson's disease (PD) research focus has been on gut-related pathology, pathophysiology, and symptoms. Gastrointestinal dysfunction, in particular constipation, affects up to 80% of PD patients ...

Diet, the gut microbiome, and colorectal cancer: are they linked?

December 9, 2016
Recent evidence from animal models suggests a role for specific types of intestinal bacteria in the development of colorectal cancer (CRC). If a microbial imbalance in the gut could actively contribute to CRC in humans, dietary-based ...

Antibiotic use in early life disrupt normal gut microbiota development

January 26, 2016
The use of antibiotics in early childhood interferes with normal development of the intestinal microbiota, shows research conducted at the University of Helsinki. Particularly the broad-spectrum macrolide antibiotics, commonly ...

Rat study shows gut microbes play a role in colon cancer susceptibility

July 13, 2016
The microscopic organisms that live in our gut do more than help us digest food. A new study in rats bolsters a growing body of evidence that the complex mix of microorganisms found in the gut, known as gut microbiota, could ...

Recommended for you

Improving vaccines for the elderly by blocking inflammation

January 22, 2018
By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.